Amyotrophic lateral sclerosis (ALS) is a disease that causes the degeneration of motor neurons, eventually leading to a loss of movement and patients being unable to breathe without assistance. We’ve put together a list of fast facts about ALS with help from the National Institute of Neurological Disorders and…
More amyotrophic lateral sclerosis (ALS) patients survived among those who completed a Phase 2 trial of MediciNova’s Ibudilast (MN-166), compared to those who dropped out of the study, according to an exploratory interim analysis. But the data, presented at the American Academy of Neurology (AAN) 2017 Annual Meeting…
In this University of California TV video, Dr. Geoffrey Sheean from the School of Medicine, UC San Diego, talks about the early stages of amyotrophic lateral sclerosis (ALS). MORE:Â Explaining the progression of ALS Dr. Sheean explains that often the first signs of the…
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the deterioration of muscles in the body, leading to loss of movement, an inability to speak and swallow, and eventually, breathe. According to medscape.com, the rate at which muscle deterioration occurs will differ from patient to…
The amyotrophic lateral sclerosis (ALS) investigational drug edaravone will be the focus of four presentations by MT Pharma America in Boston. The presentations, which include data on edaravone and an analysis evaluating clinically relevant symptoms of ALS, are taking place at the 69th Annual Meeting of the American…
Amyotrophic lateral sclerosis (ALS) and schizophrenia may be caused by similar gene mutations that affect the way neurons work, according to new research. Researchers found that 14.3 percent of the genetic variations linked to ALS were also present in people with schizophrenia, suggesting the diseases may be related. The study,…
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that attacks motor neurons, leading to wastage of the muscles. This affects every area of the body and as the disease progresses, patients begin to experience speech impairments and will eventually lose the ability to speak. MORE: Explaining the progression of ALS.
A compound that stabilizes a protein crucial for the survival of motor neurons helped cells of amyotrophic lateral sclerosis (ALS) patients survive longer in experiments performed in lab dishes. The discovery builds on research about a childhood neuromuscular disease — spinal muscular atrophy (SMA) — and may lead to new treatments…
Insights into the behavior of TDP-43 — a key protein in amyotrophic lateral sclerosis (ALS) development — may offer clues in preventing protein aggregation, potentially leading to new treatments for the disease. And the new level of understanding of how the protein is controlled and what it does in the cell…
In this video from Swallowing and Neurological Rehabilitation, LLC, speech and language pathologist (SLP), Tiffany Turner, explains some of the ways that she can help amyotrophic lateral sclerosis (ALS) patients. MORE:Â Explaining the progression of ALS Turner explains that rather than exercise, which could…
